Terumo

Basic Information

Stock Code
4543
Industry
Precision Instruments
Category Detail
Commercial & Industrial Machinery
Prefecture
Tokyo
Establishment Year
September 1921
Listing Year
June 1982
Official Website
https://www.terumo.co.jp
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
Fujifilm, PHC Holdings, Technomedica, Rion, Nihon Kohden, Sysmex, Fukuda Denshi, Yagami, Japan M.D.M., Nakanishi, Olympus, Cyberdyne

Overview

Terumo is a major medical device company founded in 1921, operating as a global enterprise with world-leading catheter and extracorporeal circulation device businesses.

Current Situation

Terumo achieved consolidated net sales of approximately 1.0361 trillion yen, operating income of approximately 157.6 billion yen, and net income of approximately 116.9 billion yen in the fiscal year ending March 2025, continuing stable growth. In the medical device field, it maintains high global market share in catheters and extracorporeal circulation devices, providing products to over 160 countries and regions. Promoting globalization, with nearly 100 consolidated subsidiaries mostly overseas entities, it has a high overseas sales ratio. In recent years, it has focused on technological innovations in extracorporeal circulation devices and development of new medical devices, deploying innovative medical solutions such as obtaining approval for regenerative medicine products. On the sustainability front, it is advancing improvements in manufacturing processes to reduce environmental impact and social contribution activities. In the medium to long term, it positions advancement of medical devices using digital technology and emerging market development as growth drivers, promoting sustainable medical device development toward 2030. Although COVID-19 reduced surgical volumes, it continues strategies to capitalize on increased demand for infection control products.

Trivia

Interesting Facts

  • Historic company founded in 1921 with Shibasaburo Kitasato and other physicians as promoters.
  • Started as thermometer manufacturer, but now less than 1% of sales.
  • Developed world's first hollow fiber artificial lung.
  • High global market share in extracorporeal circulation devices.
  • Sells world's thinnest insulin injection needle 'Nanopas 33'.
  • Over 90% of more than 100 consolidated subsidiaries are overseas entities.
  • Supported demand for extracorporeal circulation devices even during COVID-19 outbreak.
  • First in Japan to obtain approval for manufacturing and sales of regenerative medicine products.
  • Japanese medical device global leader alongside Olympus.
  • Approximately 75% global market share in guidewires for catheter treatments.
  • Company name derives from German 'thermometer'.
  • Provides UV sterilization devices in healthcare field.
  • Handles not only medical devices but also pharmaceuticals and nutritional foods.
  • Historically manufactured mercury thermometers.
  • Maintained strong performance in infection control products despite COVID-19 impact.

Hidden Connections

  • Remains strong competitor with Olympus in stock market even after alliance dissolution.
  • Overlaps in interested companies with Sysmex and Fujifilm in medical device field.
  • Deep ties with Japan Medical Association and Shibasaburo Kitasato since founding.
  • Artificial heart-lung business acquired from US 3M forms basis of global expansion.
  • Selected as constituent of major stock indices like Nikkei 225.
  • Shizuoka factory involved in document referral case for violation of Labor Safety and Health Act.
  • Continues to lead Japan's medical device industry as a centennial company.
  • Widely disseminates corporate philosophy and technology via TV Tokyo programs.

Future Outlook

Growth Drivers

  • Increasing demand for medical devices due to global aging.
  • Promotion of advanced minimally invasive treatment devices.
  • Expansion of digital health and AI medical device markets.
  • Spread of regenerative medicine products and expanded approvals.
  • Medical infrastructure development and demand growth in emerging markets.
  • Sustained and strengthened demand for infection control products.
  • New product creation through collaboration with life sciences.
  • Product development adapting to increasingly stringent regulatory environments.
  • Market expectations for sustainability-compliant products.
  • Diversification of sales channels due to digital shift in purchasing behavior.
  • Technology innovation and business expansion via overseas M&A.
  • Increased demand for related products accompanying ICT adoption in domestic medical institutions.

Strategic Goals

  • Continued expansion of share in global medical device market.
  • Mainstreaming digital medical and regenerative medicine products.
  • Establishment of manufacturing system toward carbon neutrality.
  • Deployment of data integration and DX support services for medical settings.
  • Expansion of sales networks and local production in emerging markets.
  • Ensuring sustained growth in infection control products.
  • Achieving top-tier sustainability evaluations.
  • Achieve over 40% employee diversity rate.
  • Strengthen innovation promotion systems internally and externally.
  • Growth strategy targeting over 2 trillion yen in sales by 2030.

Business Segments

Cardiovascular Treatment Devices

Overview
Provides high-performance medical devices for cardiac surgery and catheter procedures.
Competitiveness
Global market share and innovative product lineup
Customers
  • Large hospital cardiovascular surgery departments
  • Angiography facilities
  • Cardiology clinics
Products
  • Hollow Fiber Artificial Lung
  • Guidewires
  • Catheter Systems
  • Assist Circulation Systems

Infusion and Syringe Devices

Overview
Develops and sells a wide range of injection and administration medical devices.
Competitiveness
High-precision and safe product lineup
Customers
  • Hospitals
  • Pharmaceutical companies
  • Clinics
  • Syringe distributors
Products
  • Disposable Syringes
  • Prefilled Syringes
  • Infusion Pumps
  • Syringe Pumps

Blood and Component Collection Systems

Overview
Deploys safe and efficient blood collection and blood product management systems.
Competitiveness
World-leading technology with top-class global share
Customers
  • Blood donation centers
  • Blood testing labs
  • Medical institutions
Products
  • Trima Component Blood Collection Device
  • Spectra Optia Blood Component Separation Device
  • Blood Transfusion Bags

Diagnostic Reagents and Clinical Testing Supplies

Overview
Provides rapid and accurate clinical testing tools and diagnostic reagents.
Competitiveness
High technological capability and reliable product supply
Customers
  • Testing companies
  • Medical institutions
  • Pharmaceutical companies
Products
  • Blood Glucose Meters
  • Various Blood Diagnostic Reagents
  • Testing Consumables

Regenerative Medicine Products

Overview
Develops and sells cutting-edge regenerative medicine products and related devices.
Competitiveness
Possesses Japan's first regenerative medicine product for heart failure treatment
Customers
  • Regenerative medicine research institutes
  • Hospitals
  • Medical device distributors
Products
  • Skeletal Muscle-Derived Cell Sheet Products
  • Percutaneous Assist Circulation Systems

Infection Prevention and Hygiene Products

Overview
Provides hygiene-related products contributing to infection control.
Competitiveness
Product lineup trusted highly in medical settings
Customers
  • Hospitals
  • Clinics
  • Nursing homes
Products
  • Purell Hand Sanitizer
  • Infection Prevention Products
  • UV Irradiation Devices

Medical Information and Monitoring Devices

Overview
Deploys medical IT devices enhancing patient management and clinical support.
Competitiveness
Proprietary monitoring systems using IoT and communication technology
Customers
  • Hospitals
  • Remote healthcare service providers
  • Testing institutions
Products
  • HR Joint Vital Monitor
  • Pulse Oximeters
  • Remote Monitoring Systems

Pharmaceutical Manufacturing and Supply

Overview
Handles prefilled syringes and nutritional supplements.
Competitiveness
High-quality prefilled formulation technology
Customers
  • Hospitals
  • Pharmacies
  • Pharmaceutical companies
Products
  • Prefilled Syringe Products
  • Medical Nutritional Foods

Home Healthcare Devices

Overview
Provides devices and services supporting home medical care.
Competitiveness
User-centric product design
Customers
  • Home medical services
  • Patients
  • Medical device sales
Products
  • Portable Oxygen Therapy Devices
  • Home Dialysis Systems
  • Blood Glucose Monitors

Infusion Formulations and Nutritional Support

Overview
Manufactures formulations supporting patient nutrition management.
Competitiveness
Wide formulation lineup and high quality
Customers
  • Hospitals
  • Clinics
  • Welfare facilities
Products
  • High-Calorie Infusion Solutions
  • Enteral Nutritional Formulations
  • Vitamin and Electrolyte Mixtures

Medical Consumables

Overview
Supplies disposable medical supplies across a wide range.
Competitiveness
High-quality Japanese-made disposables
Customers
  • Medical facilities
  • Nursing homes
  • Wholesalers
Products
  • Injection Needles
  • Injection Tubing
  • Vaccine Administration Products

Medical Education and Technical Support

Overview
Education business supporting proper use of medical devices.
Competitiveness
Extensive experience and global responsiveness
Customers
  • Healthcare professionals
  • Hospitals
  • Educational institutions
Products
  • Technical Training Programs
  • Product Training
  • Consulting Services

Competitive Advantage

Strengths

  • World-leading medical device product lineup
  • Reliability from long history and high technological prowess
  • Strong sales base across multiple regions through global expansion
  • Innovative product development and early market entry
  • Diversified medical-related business portfolio
  • Robust network of consolidated subsidiaries
  • Solid customer base and wholesale distribution channels
  • High-precision and safe product design
  • Management emphasizing sustainability
  • Rapid business expansion capability through overseas acquisitions
  • Product lines covering diverse fields
  • Active introduction of digital medical technologies
  • Substantial R&D investment framework
  • Global production and supply network
  • Excellent education system for healthcare professionals

Competitive Advantages

  • Global leadership in artificial heart-lung devices and catheter markets
  • Pioneering technology and high market share in disposable syringes
  • Rapid response to regional needs via multinational bases
  • Advanced deployment in regenerative medicine and digital therapeutics
  • Product reliability through thorough quality control and manufacturing processes
  • Rapid market entry proficient in country-specific regulations
  • Comprehensive proposals combining wide range of medical devices and pharmaceuticals
  • Diverse lineup of infection control products
  • Successful strategic technology acquisitions through ongoing M&A
  • Strong R&D team and patent portfolio
  • High technological innovation in clinical testing products
  • Product supply aligned with global healthcare policies
  • Advancing healthcare digital transformation
  • Strong partnerships with medical institutions
  • Diverse sales channels and efficient logistics system

Threats

  • Intense price competition from global rivals
  • Impacts from changes in international regulations and approval processes
  • Risk of obsolescence of existing products due to new technologies
  • Decreases in surgeries and tests in medical settings due to infectious disease outbreaks
  • Impact of exchange rate fluctuations on earnings
  • Rising raw material prices and supply chain instability
  • Potential loss of social trust (labor issues, etc.)
  • Risk of lagging in response to rapid medical technology changes
  • IP infringement and litigation risks
  • Political and economic instability in key markets
  • Data security and personal information protection risks
  • Rise of alternative medical products

Innovations

2024: Enhanced Development of Next-Generation Cardiopulmonary Assist Systems

Overview
Advancing development of lighter, higher-function artificial lung devices.
Impact
Contributes to improved surgical success rates and shorter patient recovery periods.

2023: Construction of Digital Medical Device Integration Platform

Overview
Launched IoT-based medical device integration platform.
Impact
Significantly improves remote healthcare and patient monitoring accuracy.

2022: Launch of New Insulin Pump 'Medisafe With'

Overview
Japan's first patch-type pump revolutionizing patient convenience.
Impact
Improves QOL for users and reduces diabetes treatment burden.

2021: Introduction of Advanced Antibacterial and Adhesion Prevention Spray 'Ad Spray'

Overview
Expanded use as postoperative adhesion prevention material.
Impact
Contributes to reducing postoperative complications.

2020: Development and Provision of Novel Coronavirus Infection Control Products

Overview
Expanded UV irradiation device LightStrike and disinfectant supply.
Impact
Contributes to safety in medical facilities through infection control.

2024: Advancements in AI-Powered Vital Signs Analysis Technology

Overview
Enhanced analysis functions in HR Joint devices for advanced diagnostic support.
Impact
Contributes to rapid and accurate decision-making in medical settings.

2023: Innovation in Regenerative Medicine Product Manufacturing Technology

Overview
Optimized mass production process for skeletal muscle-derived cell sheets.
Impact
Achieves stable product supply and improved treatment efficacy.

2022: Development of World's Smallest and Most Efficient Artificial Lung

Overview
Introduced new materials and designs for mass production.
Impact
Expected to reduce patient burden and expand surgical applicability.

2021: Strengthening Global Manufacturing Bases

Overview
Established contract manufacturing base in Germany to improve supply system.
Impact
Rapid response in European market and cost reductions.

2020: Expansion of New Infection Control Product Lineup

Overview
Expanded lineup of hand sanitizers and UV sterilization devices.
Impact
Contributes to improved safety for healthcare workers and patients.

Sustainability

  • Set targets to reduce CO2 emissions in manufacturing processes
  • Develop products with recyclability and reduced environmental impact
  • Strengthen unification of environmental standards with overseas subsidiaries
  • Promote talent development emphasizing diversity and inclusion
  • Continuously implement medical support activities for local communities
  • Strengthen social responsibility in supply chains
  • Promote efficiency through medical digitalization
  • Support employee health management and work-life balance
  • Expand introduction of environmentally friendly packaging materials
  • Reduce environmental impact through green procurement